Search Result "pravastatin"
Incidence of Type 2 Diabetes Among Patients Exposed to the Combination of Pravastatin and Paroxetine
Journal: Current Drug Safety
Volume: 10 Issue: 2 Year: 2015 Page: 152-158
Author(s): Kyna M. Gooden,Kristen B. Bibeau,Jennifer Wood,Michael C. Irizarry,Xianying Pan,Jeffery Allen,Tim Sampson,Jean-Marie Heim
Rhabdomyolysis in an HIV-Infected Patient on Anti-Retroviral Therapy Precipitated by High-Dose Pravastatin
Journal: Current Drug Safety
Volume: 4 Issue: 2 Year: 2009 Page: 121-122
Author(s): Nasser Mikhail, Elizabeth Iskander, Dennis Cope
Rosuvastatin, Pravastatin, and Atorvastatin for the Treatment of Hypercholesterolaemia in HIV-Infected Patients Receiving Protease Inhibitors
Journal: Current HIV Research
Volume: 6 Issue: 6 Year: 2008 Page: 572-578
Author(s): Leonardo Calza, Roberto Manfredi, Vincenzo Colangeli, Daria Pocaterra, Michele Pavoni, Francesco Chiodo
Effects of Xuezhikang versus Pravastatin on Triglyceride Level in Patientswith T2DM and Dyslipidemia: Study Protocol for a Multicenter RandomizedControlled Trial
Journal: Current Vascular Pharmacology
Volume: 21 Issue: 3 Year: 2023 Page: 211-217
Author(s):
Synthesis, Crystal Structure and Biological Evaluation of 4, 5, 6, 7-tetrahydropravastatin as HMG-CoA Reductase Inhibitor
Journal: Letters in Drug Design & Discovery
Volume: 8 Issue: 9 Year: 2011 Page: 884-888
Author(s): Jing Li, Huan Li, Lei Zhang
Is Atorvastatin Superior to Other Statins? Analysis of the Clinical Trials with Atorvastatin Having Cardiovascular Endpoints
Journal: Reviews on Recent Clinical Trials
Volume: 1 Issue: 2 Year: 2006 Page: 143-153
Author(s): Sheila A. Doggrell
Statins: Are They All the Same?
Journal: Current Drug Therapy
Volume: 1 Issue: 2 Year: 2006 Page: 157-172
Author(s): Walter F. Riesen
Importance of Assessing the Effect of Statins on the Function of High- Density Lipoproteins on Coronary Plaque
Journal: Cardiovascular & Hematological Disorders-Drug Targets
Volume: 12 Issue: 1 Year: 2012 Page: 28-34
Author(s): Ken Kishida,Tohru Funahashi,Iichiro Shimomura
How Effective are the Lipid Modifying Medicines at Preventing Coronary Heart Disease in Patients with the Metabolic Syndrome?
Journal: Vascular Disease Prevention
Volume: 4 Issue: 2 Year: 2007 Page: 177-183
Author(s): Sheila A. Doggrell
Retrospective, Observation Study: Quantitative and Qualitative Effect of Ezetimibe and HMG-CoA Reductase Inhibitors on LDL-Cholesterol: Are There Disappearance Thresholds for Small, Dense LDL and IDL?
Journal: Recent Patents on Cardiovascular Drug Discovery (Discontinued)
Volume: 5 Issue: 2 Year: 2010 Page: 143-152
Author(s): Ikuo Inoue, Takuya Awata, Shigehiro Katayama